Condition
Pleural Malignant Mesothelioma
Estimated Enrollment: 14
Age Group: 18 Years and older (Adult, Senior)
Gender: All
Study Type: Interventional
Study Design Allocation: Primary Purpose: Treatment
Study ID Numbers: UPCC 03510
Study First Received: April 27, 2010
Last Updated: December 14, 2015
Estimated Primary Completion Date: October 2012
Primary Outcome Measures:
3-month PFS rate|Estimate the distribution of progression-free and over survival
Sponsors and Collaborators:
Abramson Cancer Center of the University of Pennsylvania
Website Link: https://ClinicalTrials.gov/show/NCT01112293
